Cardiovascular Risk Clinical Trial
Official title:
ARTEMIS - Effects of Ziltivekimab Versus Placebo on Cardiovascular Outcomes in Patients With Acute Myocardial Infarction
The research study is being done to see if ziltivekimab can be used to treat people who were admitted to hospital because of a heart attack. Ziltivekimab might reduce development of heart disease, thereby preventing new heart attacks or strokes. Participants will either get ziltivekimab (active medicine) or placebo (a dummy medicine which has no effect on the body). Which treatment participants get is decided by chance. The chance of getting ziltivekimab or placebo is the same. Ziltivekimab is not yet approved in any country or region in the world. It is a new medicine that doctors cannot prescribe. The study will last for about 2 years.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01139827 -
Association Between Framingham Risk Score, hsCRP and Vascular Inflammation: Analysis With 18F-Fluorodeoxyglucose Positron Emission Tomography
|
N/A | |
| Recruiting |
NCT05767073 -
LIVES: Personalized Lifestyle Intervention for Patients With Depression
|
N/A | |
| Completed |
NCT04626505 -
Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan.
|
Phase 2 | |
| Completed |
NCT00856882 -
The Effects of Soy Protein and Isoflavones on Glycemic Control, Insulin Sensitivity and Cardiovascular Risk Factors
|
N/A | |
| Completed |
NCT04330937 -
Clinical Trial on the Effectiveness of Citrolive
|
N/A | |
| Completed |
NCT01781416 -
Level of Concordance Between Patients Perception and Physicians Evaluation of Cardiovascular Risk
|
N/A | |
| Completed |
NCT01475513 -
Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women
|
Phase 4 | |
| Enrolling by invitation |
NCT06122961 -
Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)
|
||
| Completed |
NCT04506749 -
To Evaluate the Efficacy of a Nutraceutical in Reducing Cardiovascular Risk in Healthy Subjects
|
N/A | |
| Completed |
NCT03412175 -
CREATION Health Lifestyle Intervention
|
N/A | |
| Completed |
NCT02144922 -
Effect of Pitavastatin on Coronary Flow Reserve in Hypertensive Patients
|
Phase 4 | |
| Completed |
NCT00921752 -
C2 -CORVUS Cholesterol-Control (C2) Controlled Targets for High Vascular Risk Patients Using Effective Statins (CORVUS)
|
N/A | |
| Completed |
NCT00697580 -
Strength and Nutrition Outcomes for Latino Adolescents
|
N/A | |
| Enrolling by invitation |
NCT04450914 -
Implementing Shared Decision Making (SDM) For Individualized CV Prevention (SDM4IP)
|
N/A | |
| Completed |
NCT01003574 -
Evaluation of Cardiovascular Health Outcomes Among Survivors
|
N/A | |
| Completed |
NCT01441323 -
Strength Training and Nutrition Development for African American Youth
|
N/A | |
| Completed |
NCT01015092 -
Cardiovascular Risk Evaluation and Antiretrovirals in HIV
|
N/A | |
| Completed |
NCT01103648 -
Effect of Simvastatin and Ezetimibe on Lipid and Inflammation
|
N/A | |
| Not yet recruiting |
NCT05882266 -
The Role of Plant-Based Omega-3 Fatty Acids and Molecular Characterisation in Individuals With Cardiovascular(CVD) Risk
|
N/A | |
| Completed |
NCT00988754 -
School Based Health Promotion Program in Secondary Schools
|
N/A |